AbbVie's Q1 Good News That Investors Could Be Missing

AbbVie's Q1 Good News That Investors Could Be Missing

Source: 
Motley Fool
snippet: 
  • AbbVie lowered its 2022 adjusted earnings guidance -- but for a positive reason.
  • The company's acquisition of Allergan is clearly making a difference.
  • AbbVie's post-Humira strategy appears to already be working.